Voisard Asset Management Group, Inc. Intra Cellular Therapies, Inc. Transaction History
Voisard Asset Management Group, Inc.
- $240 Billion
- Q3 2024
A detailed history of Voisard Asset Management Group, Inc. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Voisard Asset Management Group, Inc. holds 7 shares of ITCI stock, worth $605. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7Holding current value
$605% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ITCI
# of Institutions
378Shares Held
84.7MCall Options Held
319KPut Options Held
143K-
Vanguard Group Inc Valley Forge, PA9.63MShares$832 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$546 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$457 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$333 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$264 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.16B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...